The protective effect of breastfeeding on infant inflammation: a mediation analysis of the plasma lipidome and metabolome
Authors:
- Satvika BurugupalliSBSatvika Burugupalli
- Toby MansellTMToby Mansell
- Tingting WangTWTingting Wang
- Alexandra D. GeorgeAGAlexandra D. George
- Sudip PaulSPSudip Paul
- Richard SafferyRSRichard Saffery
- Mimi L. K. TangMTMimi L. K. Tang
- Thomas W. McDadeTMThomas W. McDade
- Habtamu B. BeyeneHBHabtamu B. Beyene
- Thy DuongTDThy Duong
- Peter VuillerminPVPeter Vuillermin
- Anne-Louise PonsonbyAPAnne-Louise Ponsonby
Open Access
- 8 October 2025
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 23 (1) , 1-19
Abstract
Background: Inflammation has long-term health impacts across the life course. Breastfeeding substantially reduces inflammation risk, but key pathways, including the extent that this is due to protection against early life infection, are poorly understood. We aimed to investigate the relationships between breastfeeding, inflammation, and infection burden, and to determine the extent to which metabolomic and lipidomic profiles associated with breastfeeding mediate these health outcomes. Methods: We utilised data from the Barwon Infant Study (BIS), a longitudinal birth cohort in Victoria, Australia. Infants (n = 889) with available breastfeeding (categorised as yes/no) clinical, metabolomic, and Lipidomic data at 6 and/or 12 months were included (n = 793 at 6 months, n = 734 at 12 months). Inflammation, measured via glycoprotein acetyls (GlycA), at 6 and 12 months and infection burden, including parent-reported and medically attended infections assessed through standardised 3-monthly questionnaires were used as outcomes. Results: Any breastfeeding, regardless of supplementary feeding, was associated with lower inflammation, fewer infections, and significant, potentially beneficial changes in metabolomic and lipidomic markers, particularly plasmalogens. There was evidence of bidirectional mediation: metabolomic biomarkers and lipids mediated breastfeeding’s effects on inflammation, while inflammation partly mediated breastfeeding’s impact on certain metabolites and lipids. Conclusions: These findings highlight pathways through which breastfeeding reduces inflammation and infection burden, identifying potential targets for optimising infant feeding.Keywords
All Related Versions
Funding Information
- L.E.W. Carty Charitable Fund
- Auckland DHB Charitable Trust
- National Health and Medical Research Council
This publication has 73 references indexed in Scilit:
- High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosisEuropean Heart Journal, 2012
- Plasmalogens the neglected regulatory and scavenging lipid speciesChemistry and Physics of Lipids, 2011
- Value of Primordial and Primary Prevention for Cardiovascular DiseaseCirculation, 2011
- Breast-feeding and cardiovascular risk factors and outcomes in later life: evidence from epidemiological studiesProceedings of the Nutrition Society, 2011
- Revised birth centiles for weight, length and head circumference in the UK-WHO growth chartsAnnals of Human Biology, 2010
- The Long-Term Effects of Breastfeeding on Child and Adolescent Mental Health: A Pregnancy Cohort Study Followed for 14 YearsThe Journal of Pediatrics, 2010
- Major Lipids, Apolipoproteins, and Risk of Vascular DiseaseJAMA, 2009
- Fatty acids and immune function: new insights into mechanismsBritish Journal of Nutrition, 2007
- Mechanisms of Disease: proatherogenic HDL—an evolving fieldNature Clinical Practice Endocrinology & Metabolism, 2006
- Socioeconomic differences in childhood consultation rates in general practice in England and Wales: prospective cohort studyBMJ, 1999